Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kirsten C Morley, Paul S Haber, Madeleine L Morgan & Fares Samara. (2012) Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial. Substance Abuse and Rehabilitation 3, pages 43-47.
Read now
Read now
Élie Rizkallah, Emmanuel Stip, Simon Zhornitsky, Tania Pampoulova, Alain Gendron, Pierre-Paul Rompré, Jean-Pierre Chiasson & Stéphane Potvin. (2010) Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial. Expert Opinion on Pharmacotherapy 11:18, pages 2947-2951.
Read now
Read now
J. Peuskens, J.M. Devoitille, J. Kusters & G. Vandenhoven. (2008) An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder. International Journal of Psychiatry in Clinical Practice 12:4, pages 261-267.
Read now
Read now
Articles from other publishers (20)
Si Yang, Yan-Fang Zhang, Shao-Jia Lu, Zi-Qi Ye, Jian-Bo Lai, Lu Li, Xi Yang, Dan-Dan Wang, Pei-Fen Zhang, Ling-Ling Wu, Hui-Min Huang, Xing-Le Gao, Mian Wu, Yan-Meng Pan, Yi-Qing Chen, Dan-Hua Zhang, Yi-Meng Geng, Qing-Wei Zhao & Shao-Hua Hu. (2023) Relationship between serum concentration and clinical response of quetiapine in adolescents and adults with bipolar disorders in acute stage: a prospective observational study. Journal of Affective Disorders 324, pages 199-205.
Crossref
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
833
864
.
G. B. Kolyvanov, A. A. Litvin, R. V. Shevchenko, S. Yu. Raskin, P. O. Bochkov & V. P. Zherdev. (2021) Pharmacokinetic relationships in psychotropic drugs effects. Pharmacokinetics and Pharmacodynamics:4, pages 3-8.
Crossref
Crossref
Massimo Carlo Mauri, Silvia Paletta, Chiara Di Pace, Alessandra Reggiori, Giovanna Cirnigliaro, Isabel Valli & Alfredo Carlo Altamura. (2018) Clinical Pharmacokinetics of Atypical Antipsychotics: An Update. Clinical Pharmacokinetics 57:12, pages 1493-1528.
Crossref
Crossref
Christina W. Slotema, Jan Dirk Blom, Marieke B. A. Niemantsverdriet & Iris E. C. Sommer. (2018) Auditory Verbal Hallucinations in Borderline Personality Disorder and the Efficacy of Antipsychotics: A Systematic Review. Frontiers in Psychiatry 9.
Crossref
Crossref
Sireen A.R. Shilbayeh, Sherwin K.B. Sy, Murad Melhem, Rawan Zmeili & Hartmut Derendorf. (2015)
Quantitation of the impact of
CYP3A5
A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment
. Clinical Pharmacology in Drug Development 4:5, pages 387-394.
Crossref
Crossref
Dante Durand, Leticia L. Delgado, Dhizarah Matus de la Parra-Pellot & Diana Nichols-Vinueza. (2015) Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use. Clinical Schizophrenia & Related Psychoses 8:4, pages 205-208.
Crossref
Crossref
Qian Li, Yun Ai Su, Yi Liu, Jing Xu Chen, Yun Long Tan, Fu De Yang & Tian Mei Si. (2014) Pharmacokinetics and Tolerability of Extended-Release Quetiapine Fumarate in Han Chinese Patients with Schizophrenia. Clinical Pharmacokinetics 53:5, pages 455-465.
Crossref
Crossref
Leonardo V. Lopez & John M. Kane. (2013) Plasma levels of second-generation antipsychotics and clinical response in acute psychosis: A review of the literature. Schizophrenia Research 147:2-3, pages 368-374.
Crossref
Crossref
Simon A. Handley, Sally V.J. Bowskill, Maxine X. Patel & Robert J. Flanagan. (2012) Plasma quetiapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2000–2011. Therapeutic Advances in Psychopharmacology 3:3, pages 129-137.
Crossref
Crossref
Simon Zhornitsky, Ginette Aubin, Joelle Desfossés, Élie Rizkallah, Tania Pampoulova, Olivier Lipp, Jean-Pierre Chiasson, Emmanuel Stip & Stéphane Potvin. (2012) Predictors of Community Functioning in Schizophrenia and Substance Use Disorder Patients. Community Mental Health Journal 49:3, pages 317-322.
Crossref
Crossref
Sergio De Filippis, Ilaria Cuomo, Luana Lionetto, Delfina Janiri, Maurizio Simmaco, Matteo Caloro, Simone De Persis, Gioia Piazzi, Alessio Simonetti, C Ludovica Telesforo, Antonio Sciarretta, Federica Caccia, Giovanna Gentile, Georgios D. Kotzalidis & Paolo Girardi. (2013) Intramuscular Aripiprazole in the Acute Management of Psychomotor Agitation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33:6, pages 603-614.
Crossref
Crossref
Katrin Schroeder, Helen L. Fisher & Ingo Schäfer. (2013) Psychotic symptoms in patients with borderline personality disorder. Current Opinion in Psychiatry 26:1, pages 113-119.
Crossref
Crossref
Simon Zhornitsky, Élie Rizkallah, Tania Pampoulova, Jean-Pierre Chiasson, Olivier Lipp, Emmanuel Stip & Stéphane Potvin. (2012) Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients. Psychiatry Research 200:2-3, pages 237-241.
Crossref
Crossref
Danielle S. Fisher, Simon A. Handley, Robert J. Flanagan & David M. Taylor. (2012) Plasma Concentrations of Quetiapine, N-Desalkylquetiapine, O-Desalkylquetiapine, 7-Hydroxyquetiapine, and Quetiapine Sulfoxide in Relation to Quetiapine Dose, Formulation, and Other Factors. Therapeutic Drug Monitoring 34:4, pages 415-421.
Crossref
Crossref
A. Carlo Altamura, Donatella Moliterno, Silvia Paletta, Massimiliano Buoli, Bernardo DellʼOsso, Massimo C. Mauri & Silvio R. Bareggi. (2012) Effect of Quetiapine and Norquetiapine on Anxiety and Depression in Major Psychoses Using a Pharmacokinetic Approach. Clinical Drug Investigation 32:3, pages 213-219.
Crossref
Crossref
Simon Zhornitsky, Emmanuel Stip, Tania Pampoulova, Élie Rizkallah, Olivier Lipp, Lahcen Aït Bentaleb, Jean-Pierre Chiasson & Stéphane Potvin. (2010) Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia. Movement Disorders 25:13, pages 2188-2194.
Crossref
Crossref
David Taylor, Carol Paton & Shitij Kapur. 2009. The Maudsley Prescribing Guidelines, Tenth Edition. The Maudsley Prescribing Guidelines, Tenth Edition
1
8
.
Shailendra Kapoor. (2009) Management of borderline personality disorder: emerging, new pharmacological and non-pharmacological strategies. Acta Psychiatrica Scandinavica 119:1, pages 85-86.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:5.
Crossref
Crossref